This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karlsen, F.
Right arrow Articles by Hagmar, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karlsen, F.
Right arrow Articles by Hagmar, B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 09 1996, 2095-2100, Vol 34, No. 9
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Use of multiple PCR primer sets for optimal detection of human papillomavirus

F Karlsen, M Kalantari, A Jenkins, E Pettersen, G Kristensen, R Holm, B Johansson and B Hagmar
Department of Pathology, Norwegian Radium Hospital, Montebello, Norway. frank.karlsen@labmed.uio.no

Using multiple PCR primer sets, we tried to optimize the detection of human papillomavirus (HPV) in DNA samples isolated from 361 frozen biopsy specimens from patients with invasive cervical carcinomas. The HPVs detected were placed into three distinct groups, including group I/Inex at Telelab (Skien, Norway) and group Ineg and group II at the Norwegian Radium Hospital (Oslo, Norway). The consensus primer sets were Oli-1b-oli-2i, My09-My11, Gp5-Gp6, and Gp(5+)-Gp6+ from the HPV L1 gene and CpI-CpIIG from the E1 gene. Using these consensus primers together with the type-specific primers from E6-E7, we found that 355 patients (98%) were HPV positive. Type-specific primers for HPV types 11, 16, 18, 31, 33, and 35 detected more HPV-infected patients than the most sensitive consensus primer set, while the three consensus primer sets My, Gp/Gp+, and Cp together detected more HPV-positive patients than the type-specific primers. Testing of sensitivity of the PCR with SiHa cells serially diluted in lymphocytes (HPV-negative cells) indicated a detection limit of 6,300 HPV type 16 DNA copies with consensus primers (My, Gp+, and Cp) and 126 original HPV type 16 DNA copies with type-specific primers. Comparison of the amplification results for consensus L1 primers and type-specific E6-E7 primers indicated the presence of L1 deletions in 23 of 56 samples. The conclusion is that in PCR detection systems, multiple consensus primers and type-specific primers should be used in order to detect all patients harboring HPV.


This article has been cited by other articles:

  • Urquiza, M., Sanchez, R., Amaya, J., Leon, S., Acosta, J., Patarroyo, M. A., Camargo, M., Patarroyo, M. E. (2008). Specificity of L1 Peptides versus Virus-Like Particles for Detection of Human Papillomavirus-Positive Cervical Lesions in Females Attending Engativa Hospital, Bogota, Colombia. J. Clin. Microbiol. 46: 3714-3720 [Abstract] [Full Text]  
  • Feng, H., Taylor, J. L., Benos, P. V., Newton, R., Waddell, K., Lucas, S. B., Chang, Y., Moore, P. S. (2007). Human Transcriptome Subtraction by Using Short Sequence Tags To Search for Tumor Viruses in Conjunctival Carcinoma. J. Virol. 81: 11332-11340 [Abstract] [Full Text]  
  • Wang, P.-H., Chen, G.-D., Chang, H., Yang, S.-F., Han, C.-P., Lin, L.-Y., Ko, J.-L. (2007). High Expression of Human Telomerase Reverse Transcriptase in High-Grade Intraepithelial Neoplasia and Carcinoma of Uterine Cervix and Its Correlation With Human Papillomavirus Infection. Reproductive Sciences 14: 338-348 [Abstract]  
  • Fontaine, V., Mascaux, C., Weyn, C., Bernis, A., Celio, N., Lefevre, P., Kaufman, L., Garbar, C. (2007). Evaluation of Combined General Primer-Mediated PCR Sequencing and Type-Specific PCR Strategies for Determination of Human Papillomavirus Genotypes in Cervical Cell Specimens. J. Clin. Microbiol. 45: 928-934 [Abstract] [Full Text]  
  • Branca, M, Giorgi, C, Ciotti, M, Santini, D, Di Bonito, L, Costa, S, Benedetto, A, Bonifacio, D, Di Bonito, P, Paba, P, Accardi, L, Mariani, L, Ruutu, M, Favalli, C, Syrjanen, K, on behalf of the HPV-Pathogen Istituto Superiore d, (2006). Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer. J. Clin. Pathol. 59: 1044-1051 [Abstract] [Full Text]  
  • Gheit, T., Landi, S., Gemignani, F., Snijders, P. J. F., Vaccarella, S., Franceschi, S., Canzian, F., Tommasino, M. (2006). Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types.. J. Clin. Microbiol. 44: 2025-2031 [Abstract] [Full Text]  
  • Kraus, I., Molden, T., Holm, R., Lie, A. K., Karlsen, F., Kristensen, G. B., Skomedal, H. (2006). Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas. J. Clin. Microbiol. 44: 1310-1317 [Abstract] [Full Text]  
  • Branca, M, Giorgi, C, Santini, D, Di Bonito, L, Ciotti, M, Benedetto, A, Paba, P, Costa, S, Bonifacio, D, Di Bonito, P, Accardi, L, Favalli, C, Syrjanen, K, on behalf of the HPV-Pathogen ISS Study Group, (2006). Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J. Clin. Pathol. 59: 40-47 [Abstract] [Full Text]  
  • Szeps, M., Dahlgren, L., Aaltonen, L.-M., Ohd, J., Kanter-Lewenshon, L., Dahlstrand, H., Munck-Wikland, E., Grander, D., Dalianis, T. (2005). Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment. J. Gen. Virol. 86: 1695-1702 [Abstract] [Full Text]  
  • Molden, T., Kraus, I., Karlsen, F., Skomedal, H., Nygard, J. F., Hagmar, B. (2005). Comparison of Human Papillomavirus Messenger RNA and DNA Detection: A Cross-sectional Study of 4,136 Women >30 Years of Age with a 2-Year Follow-up of High-Grade Squamous Intraepithelial Lesion. Cancer Epidemiol. Biomarkers Prev. 14: 367-372 [Abstract] [Full Text]  
  • Rocha-Zavaleta, L., Ambrosio, J. P., Mora-Garcia, M. d. L., Cruz-Talonia, F., Hernandez-Montes, J., Weiss-Steider, B., Ortiz-Navarrete, V., Monroy-Garcia, A. (2004). Detection of antibodies against a human papillomavirus (HPV) type 16 peptide that differentiate high-risk from low-risk HPV-associated low-grade squamous intraepithelial lesions. J. Gen. Virol. 85: 2643-2650 [Abstract] [Full Text]  
  • Ha, P. K., Califano, J. A. (2004). THE ROLE OF HUMAN PAPILLOMAVIRUS IN ORAL CARCINOGENESIS. CROBM 15: 188-196 [Abstract] [Full Text]  
  • Klaassen, C. H. W., Prinsen, C. F. M., de Valk, H. A., Horrevorts, A. M., Jeunink, M. A. F., Thunnissen, F. B. J. M. (2004). DNA Microarray Format for Detection and Subtyping of Human Papillomavirus. J. Clin. Microbiol. 42: 2152-2160 [Abstract] [Full Text]  
  • Kutler, D. I., Wreesmann, V. B., Goberdhan, A., Ben-Porat, L., Satagopan, J., Ngai, I., Huvos, A. G., Giampietro, P., Levran, O., Pujara, K., Diotti, R., Carlson, D., Huryn, L. A., Auerbach, A. D., Singh, B. (2003). Human Papillomavirus DNA and p53 Polymorphisms in Squamous Cell Carcinomas From Fanconi Anemia Patients. JNCI J Natl Cancer Inst 95: 1718-1721 [Abstract] [Full Text]  
  • Sahebali, S, Depuydt, C E, Segers, K, Vereecken, A J, Van Marck, E, Bogers, J J (2003). Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool?. J. Clin. Pathol. 56: 681-686 [Abstract] [Full Text]  
  • Bachtiary, B., Schindl, M., Potter, R., Dreier, B., Knocke, T. H., Hainfellner, J. A., Horvat, R., Birner, P. (2003). Overexpression of Hypoxia-inducible Factor 1{alpha} Indicates Diminished Response to Radiotherapy and Unfavorable Prognosis in Patients Receiving Radical Radiotherapy for Cervical Cancer. Clin. Cancer Res. 9: 2234-2240 [Abstract] [Full Text]  
  • Lukaszuk, K., Liss, J., Wozniak, I., Emerich, J., Wojcikowski, C. (2003). Human Papillomavirus Type 16 Status in Cervical Carcinoma Cell DNA Assayed by Multiplex PCR. J. Clin. Microbiol. 41: 608-612 [Abstract] [Full Text]  
  • van Doorn, L.-J., Quint, W., Kleter, B., Molijn, A., Colau, B., Martin, M.-T., Kravang-In, , Torrez-Martinez, N., Peyton, C. L., Wheeler, C. M. (2002). Genotyping of Human Papillomavirus in Liquid Cytology Cervical Specimens by the PGMY Line Blot Assay and the SPF10 Line Probe Assay. J. Clin. Microbiol. 40: 979-983 [Abstract] [Full Text]  
  • Yoshinouchi, M., Hongo, A., Nakamura, K., Kodama, J., Itoh, S., Sakai, H., Kudo, T. (1999). Analysis by Multiplex PCR of the Physical Status of Human Papillomavirus Type 16 DNA in Cervical Cancers. J. Clin. Microbiol. 37: 3514-3517 [Abstract] [Full Text]  
  • Kleter, B., van Doorn, L.-J., ter Schegget, J., Schrauwen, L., van Krimpen, K., Burger, M., ter Harmsel, B., Quint, W. (1998). Novel Short-Fragment PCR Assay for Highly Sensitive Broad-Spectrum Detection of Anogenital Human Papillomaviruses. Am. J. Pathol. 153: 1731-1739 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»